Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrin-mediated cell adhesion. 1998

A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.

In this paper we show that collagenase-3 cleavage of type I collagen has a marked effect on alpha2beta1 integrin-mediated interactions with the collagen fragments generated. Isolated alpha2beta1 integrin and alpha2 integrin A-domain were found to bind to both native collagen and native 3/4 fragment and, to a lesser degree, native 1/4 fragment. Whole integrin and integrin A-domain binding were lost after heat denaturation of the collagen fragments. At physiological temperature, cell adhesion to triple-helical 3/4 fragment via alpha2beta1 integrin was still possible; however, no alpha2beta1 integrin-mediated adhesion to the 1/4 fragment was observed. Unwinding of the collagen fragment triple helices by heating to physiological temperatures prior to adsorption to plastic tissue culture plates resulted in total abrogation of HT1080 cell attachment to either fragment. These results provide significant evidence in support of a role for matrix-metalloproteinase cleavage of the extracellular matrix in modifying cell-matrix interactions.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
July 2004, The Journal of biological chemistry,
A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
May 2007, Molecular biology of the cell,
A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
November 2008, The Journal of biological chemistry,
A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
November 2008, Experimental cell research,
A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
September 1996, International journal of cancer,
A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
August 2000, Journal of cellular physiology,
A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
February 2007, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
July 2001, American journal of physiology. Cell physiology,
A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
September 2018, Journal of structural biology,
A J Messent, and D S Tuckwell, and V Knäuper, and M J Humphries, and G Murphy, and J Gavrilovic
May 2006, British journal of cancer,
Copied contents to your clipboard!